Topic: Meridia
Less than a week after the prescription weight-loss drug Meridia, also known as sibutramine, was taken off the market both in Canada and the U.S. due to heart attack and stroke risk in people who have had heart disease a generic version ...
The diet drug, Meridia, has been recently withdrawn from the market by its maker, Abbott Labs. The U.S. F.D.A., or Food and Drug Administration requested it be taken off the market. It was reported in various journals that the F.D.A. found the ...
At the request of the Food and Drug Administration, Abbott Laboratories announced today that it is withdrawing the obesity drug Meridia (sibutramine) from the market, because studies now show that the drug significantly increases the risk of serious cardiovascular events. The FDA ...
Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, almost a year after studies showed the drug increases the risk of heart attack and stroke in patients with a history of heart disease.Food and Drug ...
What You Need to Know About the Diet Pill Meridia: Meridia is a diet pill that acts as an appetite suppressant that contains Sibutramide. This diet pill is manufactured by Abbott laboratories and requires a prescription. Meridia is used in conjunction with ...
US Agency to Ask Experts to Weigh Restrictions for Diet Pill, Including Withdrawal From Market. Meridia has been sold since 1997, but data released in November showed patients with heart disease taking the drug had a more than 11 per cent risk ...
The U.S. Food and Drug Administration will ask an expert panel later this week whether or not the diet drug Meridia should be banned due to suspected heart risks.. In documents released Monday ahead of the panel meeting, which begins Wednesday, the ...
U.S. health advisers were split Wednesday over whether the diet drug Meridia should be pulled from the market, because of evidence that it increases the risk of heart attack and stroke.. In documents released Monday ahead of the panel meeting, the FDA ...
U.S. health advisers were split Wednesday over whether the diet drug Meridia should be pulled from the market, because of evidence that it increases the risk of heart attack and stroke. In documents released Monday ahead of the panel meeting, the FDA ...
FDA panel divided over whether to allow marketing of diet pill linked to heart attacksFederal health advisers delivered a split opinion Wednesday on whether to withdraw the diet pill Meridia due to evidence that it increases heart attack and stroke, with half ...
